Daisuke Fuji
Kofu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling.
Journal: Bioscience, biotechnology, and biochemistry
Published: July 28, 2023
Artificial aptamer that inhibits interleukin-23/interleukin-23 receptor interaction discovered via SELEX.
Journal: Biochemical and biophysical research communications
Published: April 17, 2022
In vitro display evolution of unnatural peptides spontaneously cyclized via intramolecular nucleophilic aromatic substitutions.
Journal: Chemical communications (Cambridge, England)
Published: April 07, 2022
Discovery of IL-5-binding unnatural cyclic peptides from multiple libraries by directed evolution.
Journal: Biochemical and biophysical research communications
Published: March 22, 2022
A human epidermal growth factor receptor 3/heregulin interaction inhibitor aptamer discovered using SELEX.
Journal: Biochemical and biophysical research communications
Published: March 10, 2021
In vitro display evolution of IL-6R-binding unnatural peptides ribosomally initiated and cyclized with m-(chloromethyl)benzoic acid.
Journal: Biochemical and biophysical research communications
Published: November 29, 2020
In vitro selection of an RNA aptamer yields an interleukin-6/interleukin-6 receptor interaction inhibitor.
Journal: Bioscience, biotechnology, and biochemistry
Published: November 14, 2020
In vitro display evolution of the PURE system-expressed TNFα-binding unnatural cyclic peptide containing an N-methyl-d-amino acid.
Journal: Biochemical and biophysical research communications
Published: November 11, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026